Assessment of Fibrosis Progression in Untreated Irish Women With Chronic Hepatitis C Contracted From Immunoglobulin Anti-D  Robert A. Levine, Schuyler O. Sanderson, Robert Ploutz–Snyder, Frank Murray, Elaine Kay, John Hegarty, Niamh Nolan, Dermot Kelleher, George Mcdonald, J. Conor O’Keane, John Crowe  Clinical Gastroenterology and Hepatology  Volume 4, Issue 10, Pages 1271-1277 (October 2006) DOI: 10.1016/j.cgh.2006.05.028 Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 1 Number of annual observations of grade () and stage (■) based on data outcomes out to 5 years. Clinical Gastroenterology and Hepatology 2006 4, 1271-1277DOI: (10.1016/j.cgh.2006.05.028) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 2 Percentage of women showing progression (worsening), improvement (regression), or no clinically important change in grade and stage from baseline measures to most recent outcome. Increasing darkness of bars indicate increasing number of years between baseline and postbaseline assessments. □, 1 year postbaseline; , 2 years postbaseline; , 3 years postbaseline; , 4 years postbaseline; ■, 5 years postbaseline. Clinical Gastroenterology and Hepatology 2006 4, 1271-1277DOI: (10.1016/j.cgh.2006.05.028) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions